Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
A085370 Stock Overview
Lutronic Corporation manufactures and sells aesthetic and medical advanced laser, and related technology worldwide.
Lutronic Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩22,250.00 |
52 Week High | ₩29,650.00 |
52 Week Low | ₩11,350.00 |
Beta | 1.13 |
1 Month Change | -21.93% |
3 Month Change | 5.95% |
1 Year Change | 80.89% |
3 Year Change | 158.42% |
5 Year Change | 73.15% |
Change since IPO | 1,919.97% |
Recent News & Updates
Shareholder Returns
A085370 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | 0.9% | 0.8% | 1.2% |
1Y | 80.9% | -4.7% | -14.3% |
Return vs Industry: A085370 exceeded the KR Medical Equipment industry which returned -4.7% over the past year.
Return vs Market: A085370 exceeded the KR Market which returned -14.3% over the past year.
Price Volatility
A085370 volatility | |
---|---|
A085370 Average Weekly Movement | 8.1% |
Medical Equipment Industry Average Movement | 5.6% |
Market Average Movement | 5.4% |
10% most volatile stocks in KR Market | 10.2% |
10% least volatile stocks in KR Market | 3.1% |
Stable Share Price: A085370 is more volatile than 75% of KR stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: A085370's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 264 | Hae-Lyung Hwang | https://int.lutronic.com |
Lutronic Corporation manufactures and sells aesthetic and medical advanced laser, and related technology worldwide. The company provides HOLLYWOOD SPECTRA, a laser platform with proprietary capabilities to reduce unwanted pigmentation and restore glowing skin; Accufit that delivers direct muscle activation treatments for an improved aesthetic appearance; LUTRONIC GENIUS, which delivers precision in every pulse; CLARITY II, a dual wavelength platform laser with breakthrough intelligent capabilities; LaseMD Ultra that provides customized outcomes with virtually no downtime for patients; and SPECTRA XT, a cutting-edge device. It also offers CLARITY, a dual-wavelength platform that enables treatment versatility and greater speed; LASEMD, an extendable platform that is able to provide a cosmeceutical delivery system program for skincare and cure; SPECTRA that provides low-downtime and efficacious treatments; PICOPLUS for the treatment of melasma; and ACTION II, a specialized multiple stacking fractional technology that combines user-selected ablation depth with coagulation control for a virtually painless procedure.
Lutronic Fundamentals Summary
A085370 fundamental statistics | |
---|---|
Market Cap | ₩581.57b |
Earnings (TTM) | ₩27.66b |
Revenue (TTM) | ₩173.64b |
20.5x
P/E Ratio3.3x
P/S RatioIs A085370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A085370 income statement (TTM) | |
---|---|
Revenue | ₩173.64b |
Cost of Revenue | ₩70.49b |
Gross Profit | ₩103.15b |
Other Expenses | ₩75.50b |
Earnings | ₩27.66b |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 1.08k |
Gross Margin | 59.40% |
Net Profit Margin | 15.93% |
Debt/Equity Ratio | 12.9% |
How did A085370 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield18%
Payout RatioValuation
Is Lutronic undervalued compared to its fair value and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
40.0%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: A085370 (₩22250) is trading below our estimate of fair value (₩37067.44)
Significantly Below Fair Value: A085370 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: A085370 is poor value based on its Price-To-Earnings Ratio (20.5x) compared to the KR Medical Equipment industry average (13.6x).
PE vs Market: A085370 is poor value based on its Price-To-Earnings Ratio (20.5x) compared to the KR market (14.1x).
Price to Earnings Growth Ratio
PEG Ratio: A085370 is good value based on its PEG Ratio (0.9x)
Price to Book Ratio
PB vs Industry: A085370 is overvalued based on its Price-To-Book Ratio (4.7x) compared to the KR Medical Equipment industry average (2.4x).
Future Growth
How is Lutronic forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Future Growth Score
5/6Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
22.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A085370's forecast earnings growth (22.5% per year) is above the savings rate (3.5%).
Earnings vs Market: A085370's earnings (22.5% per year) are forecast to grow faster than the KR market (14.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A085370's revenue (19.3% per year) is forecast to grow faster than the KR market (9.6% per year).
High Growth Revenue: A085370's revenue (19.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A085370's Return on Equity is forecast to be high in 3 years time (25.9%)
Past Performance
How has Lutronic performed over the past 5 years?
Past Performance Score
4/6Past Performance Score 4/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
2.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A085370 has high quality earnings.
Growing Profit Margin: A085370 became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: A085370 has become profitable over the past 5 years, growing earnings by 2.7% per year.
Accelerating Growth: A085370 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A085370 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (15.1%).
Return on Equity
High ROE: A085370's Return on Equity (22.8%) is considered high.
Financial Health
How is Lutronic's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: A085370's short term assets (₩137.3B) exceed its short term liabilities (₩56.6B).
Long Term Liabilities: A085370's short term assets (₩137.3B) exceed its long term liabilities (₩8.3B).
Debt to Equity History and Analysis
Debt Level: A085370 has more cash than its total debt.
Reducing Debt: A085370's debt to equity ratio has reduced from 23.4% to 12.9% over the past 5 years.
Debt Coverage: A085370's debt is well covered by operating cash flow (230.3%).
Interest Coverage: A085370's interest payments on its debt are well covered by EBIT (283.9x coverage).
Balance Sheet
Dividend
What is Lutronic current dividend yield, its reliability and sustainability?
Dividend Score
3/6Dividend Score 3/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
0.86%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: A085370's dividend (0.86%) is higher than the bottom 25% of dividend payers in the KR market (0.84%).
High Dividend: A085370's dividend (0.86%) is low compared to the top 25% of dividend payers in the KR market (2.75%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether A085370's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if A085370's dividend payments are increasing as they only just started paying a dividend.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (17.5%), A085370's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (14.5%), A085370's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
CEO
Hae-Lyung Hwang (64 yo)
no data
Tenure
Mr. Hae-Lyung Hwang serves as the Chief Executive Officer of Lutronic Corporation. Mr. Hwang served as Vice President of Laser Systems Inc. He served as a Representative of AK Tech Inc. He graduated from Y...
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Lutronic Corporation's employee growth, exchange listings and data sources
Key Information
- Name: Lutronic Corporation
- Ticker: A085370
- Exchange: KOSDAQ
- Founded: 1997
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: ₩581.573b
- Shares outstanding: 25.51m
- Website: https://int.lutronic.com
Number of Employees
Location
- Lutronic Corporation
- 219 Sowon-ro
- Deogyang-gu
- Goyang-si
- Gyeonggi-do
- South Korea
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/05/24 00:00 |
End of Day Share Price | 2022/05/24 00:00 |
Earnings | 2021/12/31 |
Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.